Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

LeMaitre Vascular Company Profile (NASDAQ:LMAT)

Consensus Ratings for LeMaitre Vascular (NASDAQ:LMAT) (?)
Ratings Breakdown: 2 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $10.58 (50.71% upside)

Analysts' Ratings History for LeMaitre Vascular (NASDAQ:LMAT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/30/2014ZacksDowngradeOutperform -> Neutral$7.90ViewTweet This Rating  Share This Rating on StockTwits
10/29/2014Canaccord GenuityReiterated RatingBuy$11.50 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
9/30/2014ZacksUpgradeNeutral -> Outperform$8.90ViewTweet This Rating  Share This Rating on StockTwits
6/24/2014Stifel NicolausInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
5/19/2014Brean CapitalInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
5/19/2014ING GroupInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
5/16/2014TheStreetDowngradeHoldViewTweet This Rating  Share This Rating on StockTwits
11/13/2013Benchmark Co.Boost Price TargetBuy$10.00 -> $11.00ViewTweet This Rating  Share This Rating on StockTwits
10/30/2013Canaccord GenuityBoost Price TargetBuy$10.50 -> $11.50ViewTweet This Rating  Share This Rating on StockTwits
10/24/2013Benchmark Co.Initiated CoverageBuy$9.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2013Roth CapitalInitiated CoverageBuy$10.00ViewTweet This Rating  Share This Rating on StockTwits
7/31/2013Canaccord GenuityBoost Price Target$9.50 -> $10.50ViewTweet This Rating  Share This Rating on StockTwits
2/27/2013Canaccord GenuityBoost Price TargetBuy$8.50 -> $9.50ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/22/2012 forward)